Literature DB >> 2145895

Breast cancer risk and history of selected medical conditions linked with female hormones.

S Franceschi1, C la Vecchia, E Negri, F Parazzini, P Boyle.   

Abstract

The relation between history of several medical conditions and procedures and risk of breast cancer was evaluated in data from a hospital-based case-control study of 2663 cases of breast cancer and 2344 controls with acute conditions unrelated to any of the established or potential risk factors for breast cancer. Whereas previous diagnosis of diabetes mellitus, thyroid disease, hypertension at any age, hyperlipidaemia, cholelithiasis, pelvic inflammatory disease and physician-diagnosed subfertility were unrelated to cancer risk, history of severe obesity in postmenopausal women (odds ratio [OR] 1.4), benign breast disease (OR 1.8) and history of breast biopsies (OR 2.4) were associated with significant risk elevation. Conversely, lifelong history of menstrual irregularities (OR 0.6) seemed to confer some protection against onset of breast cancer. This study supports the hypothesis that, unlike endometrial cancer, breast cancer risk is not enhanced by medical conditions known or suspected to be linked with female hormones, with the exception of benign breast disease and severe overweight in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145895     DOI: 10.1016/0277-5379(90)90151-i

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

1.  Hormones and risk of cancers of the breast and ovary.

Authors:  L A Brinton
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

2.  Cardiometabolic factors and breast cancer risk in U.S. black women.

Authors:  Jaclyn L F Bosco; Julie R Palmer; Deborah A Boggs; Elizabeth E Hatch; Lynn Rosenberg
Journal:  Breast Cancer Res Treat       Date:  2012-06-19       Impact factor: 4.872

3.  Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.

Authors:  C J Guigon; D W Kim; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

Review 4.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

5.  Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states.

Authors:  Dana E Rollison; Anna R Giuliano; Thomas A Sellers; Christine Laronga; Carol Sweeney; Betsy Risendal; Kathy B Baumgartner; Tim Byers; Martha L Slattery
Journal:  Am J Epidemiol       Date:  2007-11-21       Impact factor: 4.897

6.  Chronic thyroiditis in patients with advanced breast carcinoma: metabolic and morphologic changes on PET-CT.

Authors:  Ukihide Tateishi; Cristina Gamez; Shaheenah Dawood; Henry W D Yeung; Massimo Cristofanilli; Tomio Inoue; Homer A Macapinlac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-20       Impact factor: 9.236

7.  Diabetes and breast cancer risk: a meta-analysis.

Authors:  P Boyle; M Boniol; A Koechlin; C Robertson; F Valentini; K Coppens; L-L Fairley; M Boniol; T Zheng; Y Zhang; M Pasterk; M Smans; M P Curado; P Mullie; S Gandini; M Bota; G B Bolli; J Rosenstock; P Autier
Journal:  Br J Cancer       Date:  2012-09-20       Impact factor: 7.640

8.  Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.

Authors:  Ada Tosovic; Anne-Greth Bondeson; Lennart Bondeson; Ulla-Britt Ericsson; Johan Malm; Jonas Manjer
Journal:  Breast Cancer Res       Date:  2010-06-11       Impact factor: 6.466

9.  Selected medical conditions and risk of breast cancer.

Authors:  R Talamini; S Franceschi; A Favero; E Negri; F Parazzini; C La Vecchia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk.

Authors:  Hala Ahmadieh; Sami T Azar
Journal:  ISRN Endocrinol       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.